Context Therapeutics Inc. (CNTX) Q3 2024 Earnings
CNTX·Reported November 6, 2024·Before market open
Diluted EPS came in at $-0.22, missed the $-0.11 consensus by $0.11.
Diluted EPS
$-0.22missed by $0.11
Consensus: $-0.11
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Context Therapeutics Inc.'s Q3 2024 earnings report.
Context Therapeutics Inc. (CNTX) reported Q3 2024 earnings on November 6, 2024 before market open.
Context Therapeutics Inc. reported diluted EPS of $-0.22 for Q3 2024.
EPS missed the consensus estimate of $-0.11 by $0.11.
You can read the 10-Q periodic report (0001842952-24-000085) directly on SEC EDGAR. The filing index links above go to sec.gov.